Revenuesfrom Sin Taxes The additional government revenues from sin taxes are generally used to cover the societal costs created by the consumption of harmful goods (e.g., increased spending on healthcare to treat the diseases caused by smoking)
Smokeless tobacco includes chew, spit, dip, snuff, snus and a host of new dissolvable productsnone of these are safe
Simple, direct taxes work best for non-cigarette tobacco products
Establishments are required to post signs stating that sales to minors are prohibited.6,7 Minors are prohibited from buying alternative nicotine products, including e-cigarettes.6,7 Local tobacco laws The city of Chicago: Prohibits the sale of flavored tobacco products or accessories, including menthol, within 500 feet of any city high school11 Requires a retail tobacco license for the sale of e-cigarettes and bans the distribution and sale of e-cigarettes to minors, prohibits the sale of e-cigarettes within 100 feet of a school and/or day care facility, and requires e-cigarettes be stored in a manner that is not physically accessible to the public11 Bans the use of smokeless tobacco at professional and amateur sporting events, including at Wrigley Field and Guaranteed Rate Field12 Prohibits retailers from redeeming coupons or other discounts on tobacco products11 Prohibits the sale of little cigars in packages of less than 1011 Quitting statistics and benefits Quitting statistics in Illinois The CDC estimates 46.7% of daily adult smokers in Illinois quit smoking for one or more days in 2017.3 In 2014, the Affordable Care Act required that Medicaid programs cover all quit medications.7** Illinoiss state quit line invests $2.11 per smoker, compared with the national average of $2.21.7 Illinois requires that most private health insurance plans be in compliance with ACA guidance on quitting tobacco as a preventive service.7 Notes and references Updated April 2019 *National and state-level prevalence numbers reflect the most recent data available
Analyses showed that EC use was not significantly associated with prevalence of asthma, nor (as clarified by a recent erratum) past-year asthma attacks among participants with asthma, but Annals ATS [39] there was a significant interaction between EC use and sex in the analysis of past-year asthma attacks among participants with asthma (OR = 2.30, 95% CI 1.294.12 for females who used ECs vs
